⌘K

Login Start Free

Home/Insiders/Bunnage Mark E.

BM

SEC Insider//CIK 0002100735

Bunnage Mark E.

CIK 00021007351 companyBOSTON, MA

Transactions

9

Companies

1

Filings

4

CIK

0002100735

Recent Transactions

9 trades

Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-25$486.35/sh−620→ 7,284 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-24$485.11/sh−582→ 7,904 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-18$473.68/sh−1,182→ 8,486 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17$483.75/sh−1,110→ 12,105 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17+2,584→ 13,215 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17$489.46/sh−2,437→ 9,668 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-13$487.76/sh−2,283→ 10,631 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-11$460.43/sh−2,021→ 12,914 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-10$468.41/sh−1,127→ 14,935 total

Companies

1

VERTEX PHARMACEUTICALS INC / MA
EVP, Chief Scientific Officer
$VRTX

Recent Filings

4

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210

View on SEC.gov